Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $3.69

Daily Change: -$0.08 / 2.17%

Daily Range: $3.59 - $4.03

Market Cap: $315,828,576

Daily Volume: 603,361

Performance Metrics

1 Week: 6.21%

1 Month: 6.21%

3 Months: 69.35%

6 Months: -3.80%

1 Year: -50.47%

YTD: -5.04%

Company Details

Employees: 65

Sector: Health technology

Industry: Biotechnology

Country:

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

New Era Helium Inc (NEHC)

SKK Holdings Limited (SKK)

374Water Inc. (SCWO)